Calpis Co., Ltd.

Tadashi Shinoda

Naoyuki Yamamoto

Hiroshi Yoshikawa

Hidetoshi Morita

Akihiro Masuyama

Yuu Ishida

Seiichi Mizuno

Osamu Masuda

Shingo Nishimura

Kyouko Kaneko

Nagisa Ikeda

Takanobu Gotou

Daisuke Kusuda

Keiichi Matsuura

Hiroshi c/o Laboratory Of Food Science Yoshikawa

Hidetoshi c/o Laboratory Of Food Science Morita

An accelerating agent for elimination of dioxins which comprises, as an active ingredient, a microorganism having an activity of accelerating elimination of dioxins in the body to the outside of the body.

Dioxin elimination promoter

The present invention relates to a casein hydrolysate containing free amino acids and in vivo indigestible peptides having minimally suppressed in vivo enzymatic digestibility, and expected to express functions, such as hypotensive effect, in living organism, and to a method for preparing such a hydrolysate, and use thereof. The casein hydrolysate of the present invention contains free amino acids and peptides, such as in vivo indigestible peptides including Xaa-Pro and Xaa-Pro-Pro, obtained by hydrolyzing animal milk casein to have an average chain length of not longer than 2.1 in terms of the number of amino acid residues, and has ACE inhibitory activity or hypotensive effect.

Casein hydrolyzate, process for producing the same and use thereof

An agent for relieving intestinal disorders which contain live cells of a strain belonging to. This strain is preferably characterized by a resistance to a specific bile acid, adhesiveness to intestinal epithelial cells, etc. A method of controlling intestinal functions which involves the step of administering such a medicine to a subject with a need for the control of intestinal functions. When administered to humans or the like, these agents exert effects of elevating defecation frequency, etc., thereby efficaciously improving the intestinal environment.

Medicines for relieving intestinal disorders

Growing community of inventors

Sagamihara, Japan

Tadashi Shinoda